1660 related articles for article (PubMed ID: 17097736)
1. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
2. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
4. Disc hemorrhages and treatment in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Yang Z; Heijl A;
Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
[TBL] [Abstract][Full Text] [Related]
6. Natural history of open-angle glaucoma.
Heijl A; Bengtsson B; Hyman L; Leske MC;
Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
[TBL] [Abstract][Full Text] [Related]
7. Optic disc and visual field changes after trabeculectomy.
Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
[TBL] [Abstract][Full Text] [Related]
9. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
Tanito M; Itai N; Dong J; Ohira A; Chihara E
Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
[TBL] [Abstract][Full Text] [Related]
10. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
[TBL] [Abstract][Full Text] [Related]
11. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.
Lee PP; Walt JW; Rosenblatt LC; Siegartel LR; Stern LS;
Am J Ophthalmol; 2007 Dec; 144(6):901-907. PubMed ID: 17919446
[TBL] [Abstract][Full Text] [Related]
12. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
[TBL] [Abstract][Full Text] [Related]
13. Treatment and vision-related quality of life in the early manifest glaucoma trial.
Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
[TBL] [Abstract][Full Text] [Related]
14. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
15. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
[TBL] [Abstract][Full Text] [Related]
16. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
Kiuchi T; Motoyama Y; Oshika T
Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
[TBL] [Abstract][Full Text] [Related]
17. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
[TBL] [Abstract][Full Text] [Related]
18. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension.
Prasad N; Murthy S; Dagianis JJ; Latina MA
J Glaucoma; 2009 Feb; 18(2):157-60. PubMed ID: 19225355
[TBL] [Abstract][Full Text] [Related]
20. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]